{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:47Z","timestamp":1786120367378,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/sap.0b013e31824b3e06","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T05:51:10Z","timestamp":1329889870000},"page":"271-275","source":"Crossref","is-referenced-by-count":9,"title":["Reduction of Burn Scar Formation by Halofuginone-Eluting Silicone Gel Sheets"],"prefix":"10.1097","volume":"68","author":[{"given":"Philip H.","family":"Zeplin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/SCS.0b013e318175f3a7","article-title":". Prevention and management of hypertrophic scars and keloids after burns in children.","volume":"19","author":"Berman","year":"2008","journal-title":"J Craniofac Surg"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004630-200205000-00010","article-title":". The effect of silicone gel sheets on perfusion of hypertrophic burn scars.","volume":"23","author":"Musgrave","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00266-007-9030-9","article-title":"Evolution of silicone therapy and mechanism of action in scar management.","volume":"32","author":"Mustoe","year":"2008","journal-title":"Aesthetic Plast Surg"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1054\/bjps.2000.3388","article-title":". Effects of silicone gel sheet on the stratum corneum hydration.","volume":"53","author":"Suetak","year":"2000","journal-title":"Br J Plast Surg"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bjps.2008.03.022","article-title":"The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel.","volume":"61","author":"Tandara","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tibtech.2007.12.007","article-title":". Novel therapies for scar reduction and regenerative healing of skin wounds.","volume":"26","author":"Rhett","year":"2008","journal-title":"Trends Biotechnol"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1566523044578004","article-title":"TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy.","volume":"4","author":"Liu","year":"2004","journal-title":"Curr Gene Ther"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2353\/ajpath.2010.090283","article-title":". Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.","volume":"176","author":"Martinez-Ferrer","year":"2010","journal-title":"Am J Pathol"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1523-1747.1999.00477.x","article-title":". Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3.","volume":"112","author":"Chen","year":"1999","journal-title":"J Invest Dermatol"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BCR.0b013e3181a28ddb","article-title":"Transforming growth factor-beta and angiotensin in fibrosis and burn injuries.","volume":"30","author":"Gabriel","year":"2009","journal-title":"J Burn Care Res"},{"key":"R11-10-20210203","first-page":"165","article-title":"The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.","volume":"5","author":"Lin","year":"1996","journal-title":"Semin Pediatr Surg"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000658-199508000-00006","article-title":"Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair.","volume":"222","author":"Lin","year":"1995","journal-title":"Ann Surg"},{"key":"R13-10-20210203","first-page":"85","article-title":"Strategies for prevention of scars: what can we learn from fetal skin Int J Dermatol.","volume":"50","author":"Namazi","year":"2001","journal-title":""},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1524-475X.2007.00261.x","article-title":"Increased TGF-beta-producing CD4 T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring.","volume":"15","author":"Wang","year":"2007","journal-title":"Wound Repair Regen"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00042728-200809000-00008","article-title":". Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.","volume":"34","author":"Xie","year":"2008","journal-title":"Dermatol Surg"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jsre.1999.5761","article-title":". Downregulation of apoptosis-related genes in keloid tissues.","volume":"87","author":"Sayah","year":"1999","journal-title":"J Surg Res"},{"key":"R17-10-20210203","first-page":"941","article-title":". Expression of Smads in keloid scarring.","volume":"47","author":"Tang","year":"2009","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R18-10-20210203","first-page":"3459","article-title":". TGF-ss1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars.","volume":"30","author":"Bran","year":"2010","journal-title":"Anticancer Res"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/12971","article-title":". Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.","volume":"1","author":"Ashcroft","year":"1999","journal-title":"Nat Cell Biol"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response.","volume":"85","author":"Flanders","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/BCR.0b013e31819a6369","article-title":". A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns.","volume":"30","author":"Singer","year":"2009","journal-title":"J Burn Care Res"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":". Growth factors and cytokines in wound healing.","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1742-4658.2005.04703.x","article-title":". FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.","volume":"272","author":"Rahimi","year":"2005","journal-title":"FEBS J"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1054\/bjps.2002.3831","article-title":"The effect of basic fibroblast growth factor on scarring.","volume":"55","author":"Spyrou","year":"2002","journal-title":"Br J Plast Surg"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.aanat.2008.10.001","article-title":". Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars.","volume":"191","author":"Tiede","year":"2009","journal-title":"Ann Anat"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1096\/fj.07-087627","article-title":". Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells.","volume":"22","author":"Cushing","year":"2008","journal-title":"FASEB J"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajpath.2010.11.038","article-title":"Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-Smad signaling.","volume":"178","author":"Han","year":"2011","journal-title":"Am J Pathol"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.prs.0000182343.99694.28","article-title":". Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.","volume":"116","author":"Colwell","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1523-1747.ep12345771","article-title":". Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.","volume":"106","author":"Igarashi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","article-title":". Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.","volume":"181","author":"Mori","year":"1999","journal-title":"J Cell Physiol"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.bjps.2009.04.021","article-title":". Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.","volume":"63","author":"Ulrich","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.PRS.0000049450.95669.07","article-title":". TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.","volume":"111","author":"Ulrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1524-475X.1997.50404.x","article-title":". Proteolytic activity in human burn wounds.","volume":"5","author":"Neely","year":"1997","journal-title":"Wound Repair Regen"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1524-475X.1999.00166.x","article-title":". Gelatinase activity in keloids and hypertrophic scars.","volume":"7","author":"Neely","year":"1999","journal-title":"Wound Repair Regen"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-4165(93)90123-P","article-title":". Halofuginone: an inhibitor of collagen type I synthesis.","volume":"1156","author":"Granot","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.0022-202x.2001.01690.x","article-title":". Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.","volume":"118","author":"McGaha","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0306-3623(97)00307-8","article-title":"Halofuginone: a novel antifibrotic therapy.","volume":"30","author":"Pines","year":"1998","journal-title":"Gen Pharmacol"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","article-title":". Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.","volume":"9","author":"Pines","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0168-8278(02)00164-2","article-title":". Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats.","volume":"37","author":"Spira","year":"2002","journal-title":"J Hepatol"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/PRS.0b013e3181dbc313","article-title":"Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis.","volume":"126","author":"Zeplin","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.prs.0000244828.80490.62","article-title":". Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice.","volume":"119","author":"Yang","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.bjps.2006.05.007","article-title":". Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.","volume":"60","author":"Wang","year":"2007","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R43-10-20210203","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2133.2009.09511.x","article-title":"Mechanisms of transforming growth factor beta(1)Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.","volume":"162","author":"He","year":"2010","journal-title":"Br J Dermatol"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/mol.64.3.707","article-title":". 5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinaseactivator protein-1 activation.","volume":"64","author":"Wendling","year":"2003","journal-title":"Mol Pharmacol"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/mol.62.1.58","article-title":". Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.","volume":"62","author":"Laping","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R46-10-20210203","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1074\/jbc.M309798200","article-title":". Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone.","volume":"279","author":"Xavier","year":"2004","journal-title":"J Biol Chem"},{"key":"R47-10-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI12821","article-title":"Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.","volume":"108","author":"Monteleone","year":"2001","journal-title":"J Clin Invest"},{"key":"R48-10-20210203","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0006-2952(01)00753-5","article-title":". A Reduction in dermal fibrosis in the tight skin (Tsk) mouse after local application of halofuginone.","volume":"62","author":"Pines","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R49-10-20210203","doi-asserted-by":"crossref","first-page":"C1100","DOI":"10.1152\/ajpcell.00465.2005","article-title":". Autocrine loop between TGF-beta1 and IL-1 beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells.","volume":"290","author":"Aoki","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"R50-10-20210203","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.yexcr.2010.01.003","article-title":". Halofuginone inhibits Smad3 phosphorylation via the PI3KAkt and MAPKERK pathways in muscle cells: effect on myotube fusion.","volume":"316","author":"Roffe","year":"2010","journal-title":"Exp Cell Res"},{"key":"R51-10-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2007.07.030","article-title":". Involvement of ERK signaling in halofuginone-driven inhibition of fibroblast ability to contract collagen lattices.","volume":"573","author":"Tacheau","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R52-10-20210203","first-page":"1982","article-title":". Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.","volume":"5","author":"Elkin","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SAP.0b013e31824b3e06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:08Z","timestamp":1786048688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000637-201203000-00010"}},"subtitle":["A Controlled Study on Nude Mice"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e31824b3e06","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}